×
For best experience we recommend to activate Javascript in your browser.
C20orf132 antibody (AA 1-275) (HRP)
The HRP-conjugated Rabbit Polyclonal anti-C20orf132 antibody (ABIN7165834) specifically detects C20orf132 in ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN7165834
$335.48
$394.68
save $59.20 (-15 %)
Plus shipping costs $50.00
50 μL ABIN7382822
100 μL ABIN7165834
50 μL ABIN7382822
100 μL ABIN7165834
Delivery in 13 to 16 Business Days
Quick Overview for C20orf132 antibody (AA 1-275) (HRP) (ABIN7165834)
Target
C20orf132
(Chromosome 20 Open Reading Frame 132 (C20orf132))
Reactivity
All reactivities for C20orf132 antibodies
Human
Host
All hosts for C20orf132 antibodies
Rabbit
Clonality
All clonalities for C20orf132 antibodies
Polyclonal
Conjugate
All conjugates for C20orf132 antibodies
This C20orf132 antibody is conjugated to HRP
Application
All applications for C20orf132 antibodies
ELISA
Product Details anti-C20orf132 Antibody (HRP)
(hide)
Binding Specificity
All epitopes for C20orf132 antibodies
AA 1-275
Purpose
MROH8 Antibody, HRP conjugated
Purification
Protein G purified
Purity
>95 %
Immunogen
Recombinant Human Protein MROH8 protein (1-275AA)
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Preservative: 0.03 % Proclin 300 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C,-80 °C
Storage Comment
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Target Details for C20orf132
(hide)
Target
C20orf132
(Chromosome 20 Open Reading Frame 132 (C20orf132))
Alternative Name
MROH8
Background
MROH8 antibody, C20orf131 antibody, C20orf132 antibody, Protein MROH8 antibody, Maestro heat-like repeat-containing protein family member 8 antibody
UniProt
Q9H579
Recently viewed
(hide)
Chat with us , powered by LiveChat